Search Results - "Dravolina, Olga A."

Refine Results
  1. 1

    Metabotropic glutamate receptor (mGluR5) antagonist MPEP attenuated cue- and schedule-induced reinstatement of nicotine self-administration behavior in rats by Bespalov, Anton Y., Dravolina, Olga A., Sukhanov, Ilya, Zakharova, Elena, Blokhina, Elena, Zvartau, Edwin, Danysz, Wojciech, van Heeke, Gino, Markou, Athina

    Published in Neuropharmacology (2005)
    “…Previous studies suggested that metabotropic glutamate 5 (mGlu5) receptors play an important role in the reinforcing effects of abused drugs. The present…”
    Get full text
    Journal Article
  2. 2

    Study of aversive and p38 mapk-inhibitory properties of kappa-agonist with analgesic activity – compound RU-1205 by Spasov, Alexander A., Zvartau, Edwin E., Grechko, Olesya Iu, Eliseeva, Natalya V., Semenova, Yuliya V., Dravolina, Olga A., Vasiliev, Pavel M., Anisimova, Vera A.

    “…Introduction: The clinical use of kappa-opioid agonists, despite their lack of significant drug potential, is limited by the development of severe sedation,…”
    Get full text
    Journal Article
  3. 3

    Efficacy and side effects of baclofen and the novel GABA B receptor positive allosteric modulator CMPPE in animal models for alcohol and cocaine addiction by Vengeliene, Valentina, Takahashi, Tatiane T, Dravolina, Olga A, Belozertseva, Irina, Zvartau, Edwin, Bespalov, Anton Y, Spanagel, Rainer

    Published in Psychopharmacology (Berlin, Germany) (01-07-2018)
    “…Preclinical studies suggest that the GABA receptor is a potential target for treatment of substance use disorders. However, recent clinical trials report…”
    Get full text
    Journal Article
  4. 4

    mGlu1 receptor as a drug target for treatment of substance use disorders: time to gather stones together? by Dravolina, Olga A., Zvartau, Edwin, Danysz, Wojciech, Bespalov, Anton Y.

    Published in Psychopharmacology (01-05-2017)
    “…Modulation of the mGlu1 receptor was repeatedly shown to inhibit various phenomena associated with exposure to abused drugs. Efficacy in preclinical models was…”
    Get full text
    Journal Article
  5. 5

    Agonist and antagonist effects of cytisine in vivo by Radchenko, Elena V., Dravolina, Olga A., Bespalov, Anton Y.

    Published in Neuropharmacology (01-08-2015)
    “…Varenicline, the most successful smoking cessation aid, is a selective partial agonists at α4β2* nicotinic receptors. Its efficacy is likely to be shared by…”
    Get full text
    Journal Article
  6. 6

    Efficacy and side effects of baclofen and the novel GABAB receptor positive allosteric modulator CMPPE in animal models for alcohol and cocaine addiction by Vengeliene, Valentina, Takahashi, Tatiane T., Dravolina, Olga A., Belozertseva, Irina, Zvartau, Edwin, Bespalov, Anton Y., Spanagel, Rainer

    Published in Psychopharmacology (01-07-2018)
    “…Rationale Preclinical studies suggest that the GABA B receptor is a potential target for treatment of substance use disorders. However, recent clinical trials…”
    Get full text
    Journal Article
  7. 7

    Morphine-induced Straub tail reaction in mice treated with serotonergic compounds by Belozertseva, Irina V., Dravolina, Olga A., Tur, Margarita A., Semina, Marina G., Zvartau, Edwin E., Bespalov, Anton Yu

    Published in European journal of pharmacology (15-11-2016)
    “…Constitutively active 5-HT2 receptors have been suggested to contribute to motoneuronal excitability, muscle spasms and spasticity. Accordingly, 5-HT2C…”
    Get full text
    Journal Article
  8. 8

    mGlu1 receptor blockade attenuates cue- and nicotine-induced reinstatement of extinguished nicotine self-administration behavior in rats by Dravolina, Olga A., Zakharova, Elena S., Shekunova, Elena V., Zvartau, Edwin E., Danysz, Wojciech, Bespalov, Anton Y.

    Published in Neuropharmacology (01-02-2007)
    “…Glutamatergic neurotransmission is believed to be critically involved in the acquisition and maintenance of drug addiction. The present study evaluated the…”
    Get full text
    Journal Article
  9. 9

    Effects of group I metabotropic glutamate receptor antagonists on the behavioral sensitization to motor effects of cocaine in rats by DRAVOLINA, Olga A, DANYSZ, Wojciech, BESPALOV, Anton Y

    Published in Psychopharmacologia (01-09-2006)
    “…Metabotropic glutamate receptors (mGluRs) were reported to regulate various behavioral effects of addictive drugs. The present study evaluated the role of…”
    Get full text
    Journal Article
  10. 10

    Antinociceptive activity of combination of morphine and NMDA receptor antagonists depends on the inter-injection interval by Belozertseva, Irina V, Dravolina, Olga A, Neznanova, Olga N, Danysz, Wojciech, Bespalov, Anton Y

    Published in European journal of pharmacology (19-05-2000)
    “…The actual time-course of morphine antinociception is shorter than what would be predicted from its elimination kinetics, suggesting the presence of an acute…”
    Get full text
    Journal Article
  11. 11

    Effects of mGlu1 receptor blockade on working memory, time estimation, and impulsivity in rats by Sukhotina, Irina A., Dravolina, Olga A., Novitskaya, Yulia, Zvartau, Edwin E., Danysz, Wojciech, Bespalov, Anton Y.

    Published in Psychopharmacology (01-02-2008)
    “…Rationale Metabotropic glutamate 1 (mGlu1) receptor antagonists were reported to induce cognitive deficits in several animal models using aversive learning…”
    Get full text
    Journal Article
  12. 12

    Intravenous self-administration of abused solvents and anesthetics in mice by Blokhina, Elena A, Dravolina, Olga A, Bespalov, Anton Y, Balster, Robert L, Zvartau, Edwin E

    Published in European journal of pharmacology (06-02-2004)
    “…Volatile organic solvents, fuels and anesthetics are subject to abuse. The aim of the present study was to evaluate i.v. self-administration of several of…”
    Get full text
    Journal Article
  13. 13

    Effects of NMDA receptor antagonists on cocaine-conditioned motor activity in rats by Bespalov, Anton Y, Dravolina, Olga A, Zvartau, Edwin E, Beardsley, Patrick M, Balster, Robert L

    Published in European journal of pharmacology (03-03-2000)
    “…NMDA receptor antagonists have been reported to affect learned behaviors conditioned with abused drugs, with the outcome dependent, in part, on the class of…”
    Get full text
    Journal Article
  14. 14

    Effects of N-methyl-D-aspartate receptor antagonists on discriminative stimulus effects of naloxone in morphine-dependent rats using the Y-maze drug discrimination paradigm by Medvedev, I O, Dravolina, O A, Bespalov, A Y

    “…The present study assessed the ability of various site-selective N-methyl-D-aspartate (NMDA) receptor antagonists to affect the discriminative stimulus…”
    Get more information
    Journal Article
  15. 15

    Efficacy and side effects of baclofen and the novel GABA.sub.B receptor positive allosteric modulator CMPPE in animal models for alcohol and cocaine addiction by Vengeliene, Valentina, Takahashi, Tatiane T, Dravolina, Olga A, Belozertseva, Irina, Zvartau, Edwin, Bespalov, Anton Y, Spanagel, Rainer

    Published in Psychopharmacology (01-07-2018)
    “…Rationale Preclinical studies suggest that the GABA.sub.B receptor is a potential target for treatment of substance use disorders. However, recent clinical…”
    Get full text
    Journal Article
  16. 16

    Differential effects of nitric oxide synthase inhibitor, 7-nitroindazole, on discriminative stimulus and somatic effects of naloxone in morphine-dependent rats by Medvedev, Ivan O, Dravolina, Olga A, Bespalov, Anton Y

    Published in European journal of pharmacology (21-07-1999)
    “…Our previous report suggested that antagonists acting at NMDA receptors attenuate discriminative stimulus effects of naloxone in morphine dependent rats…”
    Get full text
    Journal Article
  17. 17

    Morphine Tolerance and Dependence in Mice with History of Repeated Exposures to NMDA Receptor Channel Blockers by Dravolina, Olga A, Belozertseva, Irina V, Sukhotina, Irina A, Bespalov, Anton Y

    Published in Pharmacology, biochemistry and behavior (01-08-1999)
    “…Mice were subjected to two successive treatment protocols: first with NMDA receptor channel blockers (14 days, once a day) and second with morphine (5 mg/kg, 8…”
    Get full text
    Journal Article
  18. 18

    Effects of Calcium Channel Blockers on Behaviors Induced by the N-Methyl- d-Aspartate Receptor Antagonist, Dizocilpine, in Rats by Sukhotina, Irina A, Dravolina, Olga A, Medvedev, Ivan O, Bespalov, Anton Yu

    Published in Pharmacology, biochemistry and behavior (01-08-1999)
    “…The present study assessed the ability of voltage-sensitive calcium channel (VSCC) blockers to affect the behavioral effects of the noncompetitive N-methyl-…”
    Get full text
    Journal Article
  19. 19

    Decrement in Operant Performance Produced by NMDA Receptor Antagonists in the Rat: Tolerance and Crosstolerance by Dravolina, Olga A, Zvartau, Edwin E, Bespalov, Anton Y

    Published in Pharmacology, biochemistry and behavior (01-04-2000)
    “…Current perspectives on the clinical use of NMDA receptor antagonists infer repeated administration schedules for the management of different pathological…”
    Get full text
    Journal Article
  20. 20